Expression and biological role of cytoglobin in human ovarian cancer

被引：21
作者：
Chen, Haiying [1 ]
Zhao, Xia [1 ]
Meng, Tao [1 ]
机构：
[1] China Med Univ, Dept Obstet & Gynaecol, Affiliated Hosp 1, Shenyang 110001, Liaoning, Peoples R China
来源：
TUMOR BIOLOGY | 2014年 / 35卷 / 07期
关键词：
Cytoglobin; Ovarian cancer; Proliferation; Invasion; CELL-CYCLE ARREST; LUNG-CANCER; D1; CARCINOMA; OVEREXPRESSION; PROFILES; GENE;
D O I：
10.1007/s13277-014-1941-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Loss of cytoglobin is found to be involved in the progression of several human cancers. However, its expression pattern and biological roles in human ovarian cancers are not clear. In this study, we examined cytoglobin expression in 118 archived ovarian cancer specimens using immunohistochemistry. A total of 72 specimens (61.0 %) showed cytoglobin downregulation. cytoglobin downregulation positively correlated with advanced FIGO stage and tumor grade. Cytoglobin plasmid transfection was performed in SKOV3 cell line and siRNA knockdown was carried out in SW626 cell line. MTT, colony formation assay and matrigel invasion assay were carried out to assess the role of cytoglobin on cell proliferation and invasion. Cytoglobin overexpression inhibited cell growth, invasion, cell cycle progression and cyclin D1 expression in SKOV3 cell line and its depletion promoted cell proliferation, invasion, cell cycle transition and cyclin D1 expression. In conclusion, cytoglobin is downregulated in ovarian cancers and associated with advanced stage. Our data provides evidence that cytoglobin regulates the ovarian cancer cell proliferation and invasion.
引用
收藏
页码：6933 / 6939
页数：7
相关论文
共 25 条
[1]   Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer [J].
Bali, A ;
O'Brien, PM ;
Edwards, LS ;
Sutherland, RL ;
Hacker, NF ;
Henshall, SM .
CLINICAL CANCER RESEARCH, 2004, 10 (15) :5168-5177
[2]   Cytoglobin:: A novel globin type ubiquitously expressed in vertebrate tissues [J].
Burmester, T ;
Ebner, B ;
Weich, B ;
Hankeln, T .
MOLECULAR BIOLOGY AND EVOLUTION, 2002, 19 (04) :416-421
[3]   Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies [J].
Darcy, Kathleen M. ;
Birrer, Michael J. .
GYNECOLOGIC ONCOLOGY, 2010, 117 (03) :429-439
[4]   The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment [J].
Despierre, E. ;
Lambrechts, D. ;
Neven, P. ;
Amant, F. ;
Lambrechts, S. ;
Vergote, I. .
GYNECOLOGIC ONCOLOGY, 2010, 117 (02) :358-365
[5]   Knockdown of Cytoglobin Expression Sensitizes Human Glioma Cells to Radiation and Oxidative Stress [J].
Fang, Jingye ;
Ma, Ivy ;
Allalunis-Turner, Joan .
RADIATION RESEARCH, 2011, 176 (02) :198-207
[6]   CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis [J].
Fang, Yuanyuan ;
Li, Zhengtao ;
Wang, Xiuxia ;
Zhang, Shulan .
TUMOR BIOLOGY, 2012, 33 (06) :2299-2306
[7]   miR-133a suppresses ovarian cancer cell proliferation by directly targeting insulin-like growth factor 1 receptor [J].
Guo, Jinling ;
Xia, Bairong ;
Meng, Fanling ;
Lou, Ge .
TUMOR BIOLOGY, 2014, 35 (02) :1557-1564
[8]   Cyclin D1 overexpression related to retinoblastoma protein expression as a prognostic marker in human oesophageal squamous cell carcinoma [J].
Ishikawa, T ;
Furihata, M ;
Ohtsuki, Y ;
Murakami, H ;
Inoue, A ;
Ogoshi, S .
BRITISH JOURNAL OF CANCER, 1998, 77 (01) :92-97
[9]   Cyclin D1: polymorphism, aberrant splicing and cancer risk [J].
Knudsen, KE ;
Diehl, JA ;
Haiman, CA ;
Knudsen, ES .
ONCOGENE, 2006, 25 (11) :1620-1628
[10]   Cyclin D1 Degradation Is Sufficient to Induce G1 Cell Cycle Arrest despite Constitutive Expression of Cyclin E2 in Ovarian Cancer Cells [J].
Masamha, Chioniso Patience ;
Benbrook, Doris Mangiaracina .
CANCER RESEARCH, 2009, 69 (16) :6565-6572
123